name:-0.036173820495605
name:-0.019234180450439
name:-0.03584098815918
KASHIV BIOSCIENCES, LLC Patent Filings

KASHIV BIOSCIENCES, LLC

Patent Applications and Registrations

Patent applications and USPTO patent grants for KASHIV BIOSCIENCES, LLC.The latest application filed is for "compounds useful to treat pain".

Company Profile
77.29.43
  • KASHIV BIOSCIENCES, LLC - Piscataway NJ US
  • KASHIV BIOSCIENCES, LLC - Bridgewater NJ US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Compounds Useful To Treat Pain
App 20220288093 - BRAHMKSHATRIYA; Pathik Subhashchandra ;   et al.
2022-09-15
Formulation Of Highly Concentrated Pharmacologically Active Antibody
App 20220267473 - WEAVER; Bruce ;   et al.
2022-08-25
A Process For Separation And Quantitation Of Proteins Using Capillary Electrophoresis
App 20220260521 - UPADHYAY; Roshan Ganeshlal
2022-08-18
Gastroretentive Dosage Forms Of Levodopa And Carbidopa
App 20220241184 - MEGHPARA; Kanji ;   et al.
2022-08-04
Delayed Release Methylphenidate Compositions
App 20220133635 - Vaka; Siva Ram Kiran ;   et al.
2022-05-05
Stable oral pharmaceutical composition of imatinib
Grant 11,285,152 - Purohit , et al. March 29, 2
2022-03-29
Extended release compositions comprising pyridostigmine
Grant 11,229,606 - Vaka , et al. January 25, 2
2022-01-25
Extended Release Compositions Comprising Trihexyphenidyl
App 20210330657 - Shelke; Namdev B. ;   et al.
2021-10-28
Pro-drugs Of Eliglustat
App 20210300887 - PUROHIT; Parva Yogeshchandra ;   et al.
2021-09-30
Prodrugs Of Fulvestrant
App 20210253626 - PUROHIT; Parva Yogeshchandra ;   et al.
2021-08-19
A Stable Pharmaceutical Composition Comprising Penicillamine
App 20210161846 - PUROHIT; Parva Yogeshchandra ;   et al.
2021-06-03
High-concentration Fulvestrant Compositions
App 20210145846 - Shah; Navnit H. ;   et al.
2021-05-20
Extended release compositions comprising pyridostigmine
Grant 10,987,311 - Vaka , et al. April 27, 2
2021-04-27
Opioid agonist / antagonist combination dosage forms
Grant 10,960,001 - Shah , et al. March 30, 2
2021-03-30
A Stable Oral Pharmaceutical Composition Of Ferric Citrate
App 20210077451 - PUROHIT; Parva Yogeshchandra ;   et al.
2021-03-18
Extended Release Compositions Comprising Pyridostigmine
App 20210069117 - Vaka; Siva Ram Kiran ;   et al.
2021-03-11
Programmable Pharmaceutical Compositions For Chrono Drug Release
App 20210030685 - Vaka; Siva Ram Kiran ;   et al.
2021-02-04
Self-regulating osmotic gastroretentive drug delivery systems
Grant 10,898,430 - Shah , et al. January 26, 2
2021-01-26
Programmable pharmaceutical compositions for chrono drug release
Grant 10,898,431 - Vaka , et al. January 26, 2
2021-01-26
Extended release compositions comprising pyridostigmine
Grant 10,881,617 - Vaka , et al. January 5, 2
2021-01-05
A Stable Pharmaceutical Composition Of Poorly Soluble Nonsteroidal Antiandrogens
App 20200397756 - PUROHIT; Parva Yogeshchandra ;   et al.
2020-12-24
Extended release compositions comprising trihexyphenidyl
Grant 10,869,839 - Shelke , et al. December 22, 2
2020-12-22
Gastroretentive dosage forms for sustained drug delivery
Grant 10,857,098 - Meghpara , et al. December 8, 2
2020-12-08
Self-regulating osmotic gastroretentive drug delivery systems
Grant 10,849,846 - Shah , et al. December 1, 2
2020-12-01
Self-regulating Osmotic Gastroretentive Drug Delivery Systems
App 20200330368 - Shah; Navnit H. ;   et al.
2020-10-22
Extended Release Compositions Comprising Trihexyphenidyl
App 20200261372 - Shelke; Namdev B. ;   et al.
2020-08-20
Gastroretentive Dosage Forms For Sustained Drug Delivery
App 20200261359 - Meghpara; Kanji ;   et al.
2020-08-20
Abuse-resistant drug formulations
Grant 10,744,131 - Sandhu , et al. A
2020-08-18
Extended release compositions comprising pyridostigmine
Grant 10,744,093 - Vaka , et al. A
2020-08-18
Self-regulating osmotic gastroretentive drug delivery systems
Grant 10,744,083 - Shah , et al. A
2020-08-18
Programmable Pharmaceutical Compositions For Chrono Drug Release
App 20200253861 - Kind Code
2020-08-13
A Stable Oral Pharmaceutical Composition Of Imatinib
App 20200222402 - Purohit; Parva Yogeshchandra ;   et al.
2020-07-16
Pharmaceutical Composition Comprising Eliglustat
App 20200222310 - Purohit; Parva Yogeshchandra ;   et al.
2020-07-16
Pharmaceutical Composition Comprising Eliglustat
App 20200197366 - Purohit; Parva Yogeshchandra ;   et al.
2020-06-25
Self-regulating Osmotic Gastroretentive Drug Delivery Systems
App 20200179267 - Shah; Navnit H. ;   et al.
2020-06-11
Extended Release Compositions Comprising Pyridostigmine
App 20200163889 - Vaka; Siva Ram Kiran ;   et al.
2020-05-28
Self-regulating Osmotic Gastroretentive Drug Delivery Systems
App 20200155446 - Shah; Navnit H. ;   et al.
2020-05-21
Abuse-resistant drug formulations with built-in overdose protection
Grant 10,632,113 - Vaka , et al.
2020-04-28
Extended release compositions comprising pyridostigmine
Grant 10,588,863 - Vaka , et al.
2020-03-17
Extended Release Compositions Comprising Pyridostigmine
App 20190388351 - Vaka; Siva Ram Kiran ;   et al.
2019-12-26
Extended Release Compositions Comprising Pyridostigmine
App 20190374473 - Vaka; Siva Ram Kiran ;   et al.
2019-12-12
Supersaturated stabilized nanoparticles for poorly soluble drugs
Grant 10,500,282 - Desai , et al. Dec
2019-12-10
Opioid Agonist / Antagonist Combination Dosage Forms
App 20190358221 - Shah; Navnit H. ;   et al.
2019-11-28
Method Of Manufacturing Fine Particles Suitable For Orally Disintegrating Pharmaceutical Dosage Forms
App 20190343957 - Vaka; Siva Ram Kiran ;   et al.
2019-11-14
Method of manufacturing fine particles suitable for orally disintegrating pharmaceutical dosage forms
Grant 10,406,234 - Vaka , et al. Sept
2019-09-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed